*1Okwuraiwe, A. P., 1Audu, R. A., 1Ige, F. A., 1Salu, O. B., 1Onwuamah, C. K., & 2Musa, A. Z.
1Centre for Human Virology and Genomics, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria 2Clinical Sciences Division, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria *Correspondence to: azukaokwu@yahoo.com; apokwuraiwe@nimr.gov.ng; +2347039303050
Abstract:
Background: HIV co-infection with hepatitis B (HBV) and/or hepatitis C virus (HCV) is common, largely due to shared routes of transmission, but paucity of data exists for long term treatment outcomes of HIV infected patients, and those co-infected with HBV and HCV despite the high burden in Nigeria. The aim of study was to describe the long-term treatment outcomes in HIV infected Nigerians and to assess the effect of HBV and HCV co-infections on long-term response to antiretroviral therapy (ART). Continue reading “Long term outcomes of highly active antiretroviral therapy in HIV infected Nigerians and those co-infected with hepatitis B and C viruses”